Works matching AU Nishio, Makoto

Results: 126

Targeting ErbB and tankyrase1/2 prevent the emergence of drug-tolerant persister cells in ALK-positive lung cancer.

Published in:

NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00757-w

By:

Fujimura, Takaaki;
Furugaki, Koh;
Mizuta, Hayato;
Muraoka, Satoshi;
Nishio, Makoto;
Adachi, Jun;
Uchibori, Ken;
Miyauchi, Eisaku;
Hayashi, Hidetoshi;
Katayama, Ryohei;
Yoshiura, Shigeki

Publication type:

Article

RELAY, Ramucirumab Plus Erlotinib (RAM+ERL) in Untreated Metastatic EGFR-Mutant NSCLC (EGFR+ NSCLC): Association Between TP53 Status and Clinical Outcome.

Published in:

Clinical Lung Cancer, 2023, v. 24, n. 5, p. 415, doi. 10.1016/j.cllc.2023.02.010

By:

Makoto Nishio;
Paz-Ares, Luis;
Reck, Martin;
Kazuhiko Nakagawa;
Garon, Edward B.;
Popat, Sanjay;
Ceccarelli, Matteo;
Graham, Hillary T.;
Visseren-Grul, Carla;
Novello, Silvia

Publication type:

Article

A Reasonable Definition of Oligo-Recurrence in Non–Small-Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 1, p. 82, doi. 10.1016/j.cllc.2021.10.013

By:

Sonoda, Dai;
Matsuura, Yosuke;
Kondo, Yasuto;
Ichinose, Junji;
Nakao, Masayuki;
Ninomiya, Hironori;
Nishio, Makoto;
Okumura, Sakae;
Satoh, Yukitoshi;
Mun, Mingyon

Publication type:

Article

Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer.

Published in:

2021

By:

Yamamoto, Nobuyuki;
Harada, Hideyuki;
Okamoto, Isamu;
Masuda, Noriyuki;
Hayakawa, Kazushige;
Satouchi, Miyako;
Soejima, Toshinori;
Nishio, Makoto;
Kozuka, Takuyo;
Takeda, Koji;
Tanaka, Masahiro;
Seto, Takashi;
Sasaki, Tomonari;
Tsubouchi, Hiroshi;
Kakurai, Yasuyuki;
Nishimura, Yasumasa;
Nakagawa, Kazuhiko

Publication type:

journal article

Utility of Maximum CT Value in Predicting the Invasiveness of Pure Ground-Glass Nodules.

Published in:

2020

By:

Ichinose, Junji;
Kawaguchi, Yohei;
Nakao, Masayuki;
Matsuura, Yosuke;
Okumura, Sakae;
Ninomiya, Hironori;
Oikado, Katsunori;
Nishio, Makoto;
Mun, Mingyon

Publication type:

journal article

Subgroup Analysis of Japanese Patients in a Phase III Study of Atezolizumab in Extensive-stage Small-cell Lung Cancer (IMpower133).

Published in:

2019

By:

Nishio, Makoto;
Sugawara, Shunichi;
Atagi, Shinji;
Akamatsu, Hiroaki;
Sakai, Hiroshi;
Okamoto, Isamu;
Takayama, Koichi;
Hayashi, Hidetoshi;
Nakagawa, Yuki;
Kawakami, Tomohisa

Publication type:

journal article

Phase 1 Study of Cabozantinib in Japanese Patients With Expansion Cohorts in Non-Small-Cell Lung Cancer.

Published in:

2019

By:

Nokihara, Hiroshi;
Nishio, Makoto;
Yamamoto, Noboru;
Fujiwara, Yutaka;
Horinouchi, Hidehito;
Kanda, Shintaro;
Horiike, Atsushi;
Ohyanagi, Fumiyoshi;
Yanagitani, Noriko;
Nguyen, Linh;
Yaron, Yifah;
Borgman, Anne;
Tamura, Tomohide

Publication type:

journal article

Characterization of Computed Tomography Imaging of Rearranged During Transfection-rearranged Lung Cancer.

Published in:

2018

By:

Masafumi Saiki;
Satoru Kitazono;
Takahiro Yoshizawa;
Yosuke Dotsu;
Ryo Ariyasu;
Junji Koyama;
Tomoaki Sonoda;
Ken Uchibori;
Shingo Nishikawa;
Noriko Yanagitani;
Atsushi Horiike;
Fumiyoshi Ohyanagi;
Katsunori Oikado;
Hironori Ninomiya;
Kengo Takeuchi;
Yuichi Ishikawa;
Makoto Nishio;
Saiki, Masafumi;
Kitazono, Satoru;
Yoshizawa, Takahiro

Publication type:

journal article

EBUS-TBNA as a Promising Method for the Evaluation of Tumor PD-L1 Expression in Lung Cancer.

Published in:

2017

By:

Rie Sakakibara;
Kentaro Inamura;
Yuichi Tambo;
Hironori Ninomiya;
Satoru Kitazono;
Noriko Yanagitani;
Atsushi Horiike;
Fumiyoshi Ohyanagi;
Yosuke Matsuura;
Masayuki Nakao;
Mingyon Mun;
Sakae Okumura;
Naohiko Inase;
Makoto Nishio;
Noriko Motoi;
Yuichi Ishikawa;
Sakakibara, Rie;
Inamura, Kentaro;
Tambo, Yuichi;
Ninomiya, Hironori

Publication type:

journal article

Analysis of Epidermal Growth Factor Receptor Mutations in Serum Among Japanese Patients Treated With First-Line Erlotinib for Advanced Non-Small-Cell Lung Cancer.

Published in:

2016

By:

Nishio, Makoto;
Goto, Koichi;
Chikamori, Kenichi;
Hida, Toyoaki;
Katakami, Nobuyuki;
Maemondo, Makoto;
Ohishi, Norihisa;
Tamura, Tomohide

Publication type:

journal article

Analysis of Epidermal Growth Factor Receptor Mutations in Serum Among Japanese Patients Treated With First-Line Erlotinib for Advanced Non--Small-Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2016, v. 17, n. 1, p. 24, doi. 10.1016/j.cllc.2015.07.001

By:

Makoto Nishio;
Koichi Goto;
Kenichi Chikamori;
Toyoaki Hida;
Nobuyuki Katakami;
Makoto Maemondo;
Norihisa Ohishi;
Tomohide Tamura

Publication type:

Article

Dose-Escalation Study of Three-Dimensional Conformal Thoracic Radiotherapy With Concurrent S-1 and Cisplatin for Inoperable Stage III Non-Small-Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2013, v. 14, n. 4, p. 440, doi. 10.1016/j.cllc.2013.01.003

By:

Harada, Hideyuki;
Nishio, Makoto;
Murakami, Haruyasu;
Ohyanagi, Fumiyoshi;
Kozuka, Takuyo;
Ishikura, Satoshi;
Naito, Tateaki;
Kaira, Kyoichi;
Takahashi, Toshiaki;
Horiike, Atsushi;
Nishimura, Tetsuo;
Yamamoto, Nobuyuki

Publication type:

Article

Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.

Published in:

Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 106, doi. 10.1093/jjco/hyaa157

By:

Saka, Hideo;
Nishio, Makoto;
Hida, Toyoaki;
Nakagawa, Kazuhiko;
Sakai, Hiroshi;
Nogami, Naoyuki;
Atagi, Shinji;
Takahashi, Toshiaki;
Horinouchi, Hidehito;
Takenoyama, Mitsuhiro;
Katakami, Nobuyuki;
Tanaka, Hiroshi;
Takeda, Koji;
Satouchi, Miyako;
Isobe, Hiroshi;
Maemondo, Makoto;
Goto, Koichi;
Hirashima, Tomonori;
Minato, Koichi;
Yada, Nobumichi

Publication type:

Article

Pharmacokinetic and Exposure–Response Modeling Support Body Surface Area‐Based Dosing of Farletuzumab Ecteribulin in Japanese Patients with Solid Tumors.

Published in:

Journal of Clinical Pharmacology, 2025, v. 65, n. 6, p. 751, doi. 10.1002/jcph.6187

By:

Hayato, Seiichi;
Hamuro, Lora;
Shimizu, Toshio;
Yonemori, Kan;
Nishio, Shin;
Yunokawa, Mayu;
Yoshida, Tatsuya;
Nishio, Makoto;
Matsumoto, Koji;
Takehara, Kazuhiro;
Hasegawa, Kosei;
Kozuki, Toshiyuki;
Hirashima, Yasuyuki;
Kato, Hidenori;
Miura, Takuma;
Nomoto, Maiko;
Zhao, Yue;
Zhu, Li;
Yasuda, Sanae

Publication type:

Article

Management of Peripheral Edema in Patients with MET Exon 14-Mutated Non-small Cell Lung Cancer Treated with Small Molecule MET Inhibitors.

Published in:

2022

By:

Nishio, Makoto;
Kato, Terufumi;
Toyozawa, Ryo;
Hida, Toyoaki

Publication type:

journal article

Drug interactions between tyrosine kinase inhibitors (gefitinib and erlotinib) and warfarin: Assessment of international normalized ratio elevation characteristics and in vitro CYP2C9 activity.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 7, p. 1599, doi. 10.1177/1078155218801061

By:

Hiraide, Makoto;
Minowa, Yuichi;
Nakano, Yasuhiro;
Suzuki, Kenichi;
Shiga, Taro;
Nishio, Makoto;
Miyoshi, Junya;
Takahashi, Harumi;
Hama, Toshihiro

Publication type:

Article

Association Between the Efficacy of Pembrolizumab and Low STK11/LKB1 Expression in High-PD-L1-expressing Non-small-cell Lung Cancer.

Published in:

In Vivo, 2020, v. 34, n. 5, p. 2997, doi. 10.21873/invivo.12131

By:

TSUKASA HASEGAWA;
NORIKO YANAGITANI;
HIRONORI NINOMIYA;
HIROAKI SAKAMOTO;
TAKEHIRO TOZUKA;
HIROSHI YOSHIDA;
YOSHIAKI AMINO;
SHINYA UEMATSU;
TAKAHIRO YOSHIZAWA;
RYO ARIYASU;
KEN UCHIBORI;
SATORU KITAZONO;
ATSUSHI HORIIKE;
MAKOTO NISHIO

Publication type:

Article

Characteristics and outcomes of patients with EGFR-mutation positive non-small-cell lung cancer receiving gefitinib beyond radiological progression.

Published in:

Expert Opinion on Pharmacotherapy, 2018, v. 19, n. 10, p. 1049, doi. 10.1080/14656566.2018.1484903

By:

Hosomi, Yukio;
Tanai, Chiharu;
Yoh, Kiyotaka;
Goto, Yasushi;
Sakai, Hiroshi;
Kato, Terufumi;
Kaburagi, Takayuki;
Nishio, Makoto;
Kim, Young Hak;
Inoue, Akira;
Hasegawa, Yoshinori;
Isobe, Hiroshi;
Tomizawa, Yoshio;
Mori, Yoshiaki;
Minato, Koichi;
Yamada, Kazuhiko;
Ohashi, Yasuo;
Kunitoh, Hideo

Publication type:

Article

AXL‐Mediated Drug Resistance in ALK‐Rearranged NSCLC Enhanced by GAS6 From Macrophages and MMP11 Positive Fibroblasts.

Published in:

Cancer Science, 2025, v. 116, n. 4, p. 1034, doi. 10.1111/cas.70006

By:

Utsumi, Takahiro;
Mizuta, Hayato;
Seto, Yosuke;
Uchibori, Ken;
Nishio, Makoto;
Okamoto, Isamu;
Katayama, Ryohei

Publication type:

Article

Brigatinib in Japanese patients with ALK‐positive non‐small‐cell lung cancer: Final results of the phase 2 J‐ALTA trial.

Published in:

Cancer Science, 2023, v. 114, n. 9, p. 3698, doi. 10.1111/cas.15888

By:

Yoshida, Tatsuya;
Kumagai, Toru;
Toyozawa, Ryo;
Katayama, Ryohei;
Nishio, Makoto;
Seto, Takashi;
Goto, Koichi;
Yamamoto, Nobuyuki;
Ohe, Yuichiro;
Kudou, Kentarou;
Asato, Takayuki;
Zhang, Pingkuan;
Nakagawa, Kazuhiko

Publication type:

Article

Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407.

Published in:

Cancer Science, 2023, v. 114, n. 8, p. 3330, doi. 10.1111/cas.15816

By:

Sugawara, Shunichi;
Tanaka, Kentaro;
Imamura, Fumio;
Yamamoto, Nobuyuki;
Nishio, Makoto;
Okishio, Kyoichi;
Hirashima, Tomonori;
Tanaka, Hiroshi;
Fukuhara, Tatsuro;
Nakahara, Yasuharu;
Kurata, Takayasu;
Katakami, Nobuyuki;
Okada, Morihito;
Horinouchi, Hidehito;
Udagawa, Hibiki;
Kasahara, Kazuo;
Satouchi, Miyako;
Saka, Hideo;
Tokito, Takaaki;
Hosomi, Yukio

Publication type:

Article

Real‐world study of next‐generation sequencing diagnostic biomarker testing for patients with lung cancer in Japan.

Published in:

Cancer Science, 2023, v. 114, n. 6, p. 2524, doi. 10.1111/cas.15752

By:

Takahashi, Toshiaki;
Nishio, Makoto;
Nishino, Kazumi;
Yoshiki, Yasumasa;
Shiraiwa, Naoko;
Emir, Birol;
Iadeluca, Laura;
Yatabe, Yasushi;
Nishio, Kazuto

Publication type:

Article

Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK‐rearranged non–small cell lung cancer.

Published in:

Cancer Science, 2022, v. 113, n. 11, p. 3888, doi. 10.1111/cas.15529

By:

Sakashita, Takuya;
Yanagitani, Noriko;
Koike, Sumie;
Low, Siew‐Kee;
Takagi, Satoshi;
Baba, Satoko;
Takeuchi, Kengo;
Nishio, Makoto;
Fujita, Naoya;
Katayama, Ryohei

Publication type:

Article

Pembrolizumab plus pemetrexed‐platinum for metastatic nonsquamous non–small‐cell lung cancer: KEYNOTE‐189 Japan Study.

Published in:

Cancer Science, 2021, v. 112, n. 8, p. 3255, doi. 10.1111/cas.14980

By:

Horinouchi, Hidehito;
Nogami, Naoyuki;
Saka, Hideo;
Nishio, Makoto;
Tokito, Takaaki;
Takahashi, Toshiaki;
Kasahara, Kazuo;
Hattori, Yoshihiro;
Ichihara, Eiki;
Adachi, Noriaki;
Noguchi, Kazuo;
Souza, Fabricio;
Kurata, Takayasu

Publication type:

Article

Monitoring epidermal growth factor receptor C797S mutation in Japanese non–small cell lung cancer patients with serial cell‐free DNA evaluation using digital droplet PCR.

Published in:

Cancer Science, 2021, v. 112, n. 6, p. 2371, doi. 10.1111/cas.14879

By:

Ariyasu, Ryo;
Uchibori, Ken;
Sasaki, Takaaki;
Tsukahara, Mika;
Kiyotani, Kazuma;
Yoshida, Ryohei;
Ono, Yusuke;
Kitazono, Satoru;
Ninomiya, Hironori;
Ishikawa, Yuichi;
Mizukami, Yusuke;
Yanagitani, Noriko;
Fujita, Naoya;
Nishio, Makoto;
Katayama, Ryohei

Publication type:

Article

IMpower132: Atezolizumab plus platinum‐based chemotherapy vs chemotherapy for advanced NSCLC in Japanese patients.

Published in:

Cancer Science, 2021, v. 112, n. 4, p. 1534, doi. 10.1111/cas.14817

By:

Nishio, Makoto;
Saito, Haruhiro;
Goto, Koichi;
Watanabe, Satoshi;
Sueoka‐Aragane, Naoko;
Okuma, Yusuke;
Kasahara, Kazuo;
Chikamori, Kenichi;
Nakagawa, Yuki;
Kawakami, Tomohisa

Publication type:

Article

Capmatinib in Japanese patients with MET exon 14 skipping–mutated or MET‐amplified advanced NSCLC: GEOMETRY mono‐1 study.

Published in:

Cancer Science, 2021, v. 112, n. 4, p. 1556, doi. 10.1111/cas.14826

By:

Seto, Takashi;
Ohashi, Kadoaki;
Sugawara, Shunichi;
Nishio, Makoto;
Takeda, Masayuki;
Aoe, Keisuke;
Moizumi, Sanae;
Nomura, Satoshi;
Tajima, Takeshi;
Hida, Toyoaki

Publication type:

Article

Ramucirumab or placebo plus erlotinib in EGFR‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY.

Published in:

Cancer Science, 2020, v. 111, n. 12, p. 4510, doi. 10.1111/cas.14655

By:

Nishio, Makoto;
Seto, Takashi;
Reck, Martin;
Garon, Edward B.;
Chiu, Chao‐Hua;
Yoh, Kiyotaka;
Imamura, Fumio;
Park, Keunchil;
Shih, Jin‐Yuan;
Visseren‐Grul, Carla;
Frimodt‐Moller, Bente;
Zimmermann, Annamaria;
Homma, Gosuke;
Enatsu, Sotaro;
Nakagawa, Kazuhiko

Publication type:

Article

Lorlatinib in previously treated anaplastic lymphoma kinase‐rearranged non–small cell lung cancer: Japanese subgroup analysis of a global study.

Published in:

Cancer Science, 2020, v. 111, n. 10, p. 3726, doi. 10.1111/cas.14576

By:

Seto, Takashi;
Hayashi, Hidetoshi;
Satouchi, Miyako;
Goto, Yasushi;
Niho, Seiji;
Nogami, Naoyuki;
Hida, Toyoaki;
Takahashi, Toshiaki;
Sakakibara‐Konishi, Jun;
Morise, Masahiro;
Nagasawa, Takashi;
Suzuki, Mie;
Ohkura, Masayuki;
Fukuhara, Kei;
Thurm, Holger;
Peltz, Gerson;
Nishio, Makoto

Publication type:

Article

Safety and efficacy of first‐line dacomitinib in Japanese patients with advanced non‐small cell lung cancer.

Published in:

Cancer Science, 2020, v. 111, n. 5, p. 1724, doi. 10.1111/cas.14384

By:

Nishio, Makoto;
Kato, Terufumi;
Niho, Seiji;
Yamamoto, Noboru;
Takahashi, Toshiaki;
Nogami, Naoyuki;
Kaneda, Hiroyasu;
Fujita, Yuka;
Wilner, Keith;
Yoshida, Mizuki;
Isozaki, Mitsuhiro;
Wada, Shinsuke;
Tsuji, Fumito;
Nakagawa, Kazuhiko

Publication type:

Article

Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms.

Published in:

Cancer Science, 2020, v. 111, n. 3, p. 932, doi. 10.1111/cas.14314

By:

Yanagitani, Noriko;
Uchibori, Ken;
Koike, Sumie;
Tsukahara, Mika;
Kitazono, Satoru;
Yoshizawa, Takahiro;
Horiike, Atsushi;
Ohyanagi, Fumiyoshi;
Tambo, Yuichi;
Nishikawa, Shingo;
Fujita, Naoya;
Katayama, Ryohei;
Nishio, Makoto

Publication type:

Article

Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients.

Published in:

Cancer Science, 2019, v. 110, n. 10, p. 3350, doi. 10.1111/cas.14153

By:

Kitazono, Satoru;
Sakai, Kazuko;
Yanagitani, Noriko;
Ariyasu, Ryo;
Yoshizawa, Takahiro;
Dotsu, Yosuke;
Koyama, Junji;
Saiki, Masafumi;
Sonoda, Tomoaki;
Nishikawa, Shingo;
Uchibori, Ken;
Horiike, Atsushi;
Nishio, Kazuto;
Nishio, Makoto

Publication type:

Article

Osimertinib for Japanese patients with T790M‐positive advanced non‐small‐cell lung cancer: A pooled subgroup analysis.

Published in:

Cancer Science, 2019, v. 110, n. 9, p. 2884, doi. 10.1111/cas.14120

By:

Hirashima, Tomonori;
Satouchi, Miyako;
Hida, Toyoaki;
Nishio, Makoto;
Kato, Terufumi;
Sakai, Hiroshi;
Imamura, Fumio;
Kiura, Katsuyuki;
Okamoto, Isamu;
Kasahara, Kazuo;
Uchida, Hirohiko;
Vowler, Sarah L.;
Mitsudomi, Tetsuya

Publication type:

Article

KEYNOTE‐025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1–positive advanced non–small‐cell lung cancer.

Published in:

Cancer Science, 2019, v. 110, n. 3, p. 1012, doi. 10.1111/cas.13932

By:

Nishio, Makoto;
Takahashi, Toshiaki;
Yoshioka, Hiroshige;
Nakagawa, Kazuhiko;
Fukuhara, Tatsuro;
Yamada, Kazuhiko;
Ichiki, Masao;
Tanaka, Hiroshi;
Seto, Takashi;
Sakai, Hiroshi;
Kasahara, Kazuo;
Satouchi, Miyako;
Han, Shi Rong;
Noguchi, Kazuo;
Shimamoto, Takashi;
Kato, Terufumi

Publication type:

Article

Exploration of resistance mechanisms for epidermal growth factor receptor‐tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next‐generation sequencing.

Published in:

Cancer Science, 2018, v. 109, n. 12, p. 3921, doi. 10.1111/cas.13820

By:

Iwama, Eiji;
Sakai, Kazuko;
Azuma, Koichi;
Harada, Daijiro;
Nosaki, Kaname;
Hotta, Katsuyuki;
Nishio, Makoto;
Kurata, Takayasu;
Fukuhara, Tatsuro;
Akamatsu, Hiroaki;
Goto, Koichi;
Shimose, Takayuki;
Kishimoto, Junji;
Nakanishi, Yoichi;
Nishio, Kazuto;
Okamoto, Isamu

Publication type:

Article

Clinical activity of ASP8273 in Asian patients with non‐small‐cell lung cancer with EGFR activating and T790M mutations.

Published in:

Cancer Science, 2018, v. 109, n. 9, p. 2852, doi. 10.1111/cas.13724

By:

Murakami, Haruyasu;
Nokihara, Hiroshi;
Hayashi, Hidetoshi;
Seto, Takashi;
Park, Keunchil;
Azuma, Koichi;
Tsai, Chun‐Ming;
Yang, James Chih‐Hsin;
Nishio, Makoto;
Kim, Sang‐We;
Kiura, Katsuyuki;
Inoue, Akira;
Takeda, Koji;
Kang, Jin‐Hyoung;
Nakagawa, Tomoki;
Takeda, Kentaro;
Akazawa, Rio;
Kaneko, Yuichiro;
Shimazaki, Masashi;
Morita, Satoshi

Publication type:

Article

Phase II study of ceritinib in alectinib‐pretreated patients with anaplastic lymphoma kinase‐rearranged metastatic non‐small‐cell lung cancer in Japan: ASCEND‐9.

Published in:

Cancer Science, 2018, v. 109, n. 9, p. 2863, doi. 10.1111/cas.13721

By:

Hida, Toyoaki;
Seto, Takashi;
Horinouchi, Hidehito;
Maemondo, Makoto;
Takeda, Masayuki;
Hotta, Katsuyuki;
Hirai, Fumihiko;
Kim, Young Hak;
Matsumoto, Shingo;
Ito, Masayuki;
Ayukawa, Koichi;
Tokushige, Kota;
Yonemura, Masataka;
Mitsudomi, Testuya;
Nishio, Makoto

Publication type:

Article

ASP8273 tolerability and antitumor activity in tyrosine kinase inhibitor‐naïve Japanese patients with EGFR mutation‐positive non‐small‐cell lung cancer.

Published in:

Cancer Science, 2018, v. 109, n. 8, p. 2532, doi. 10.1111/cas.13651

By:

Azuma, Koichi;
Nishio, Makoto;
Hayashi, Hidetoshi;
Kiura, Katsuyuki;
Satouchi, Miyako;
Sugawara, Shunichi;
Hida, Toyoaki;
Iwamoto, Yasuo;
Inoue, Akira;
Takeda, Koji;
Ikeda, Satoshi;
Nakagawa, Tomoki;
Takeda, Kentaro;
Asahina, Seitaro;
Komatsu, Kanji;
Morita, Satoshi;
Fukuoka, Masahiro;
Nakagawa, Kazuhiko

Publication type:

Article

Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.

Published in:

Cancer Science, 2017, v. 108, n. 5, p. 1000, doi. 10.1111/cas.13225

By:

Hida, Toyoaki;
Nishio, Makoto;
Nogami, Naoyuki;
Ohe, Yuichiro;
Nokihara, Hiroshi;
Sakai, Hiroshi;
Satouchi, Miyako;
Nakagawa, Kazuhiko;
Takenoyama, Mitsuhiro;
Isobe, Hiroshi;
Fujita, Shiro;
Tanaka, Hiroshi;
Minato, Koichi;
Takahashi, Toshiaki;
Maemondo, Makoto;
Takeda, Koji;
Saka, Hideo;
Goto, Koichi;
Atagi, Shinji;
Hirashima, Tomonori

Publication type:

Article

Pharmacologic study ( JP28927) of alectinib in Japanese patients with ALK+ non-small-cell lung cancer with or without prior crizotinib therapy.

Published in:

Cancer Science, 2016, v. 107, n. 11, p. 1642, doi. 10.1111/cas.13066

By:

Hida, Toyoaki;
Nakagawa, Kazuhiko;
Seto, Takashi;
Satouchi, Miyako;
Nishio, Makoto;
Hotta, Katsuyuki;
Takahashi, Toshiaki;
Ohe, Yuichiro;
Takeda, Koji;
Tatsuno, Masahiro;
Asakawa, Takashi;
Shimada, Tadashi;
Tanaka, Tomohiro;
Tamura, Tomohide

Publication type:

Article

Feasibility study of chemoradiotherapy followed by amrubicin and cisplatin for limited-disease small cell lung cancer.

Published in:

Cancer Science, 2016, v. 107, n. 3, p. 315, doi. 10.1111/cas.12875

By:

Sekine, Ikuo;
Sumi, Minako;
Satouchi, Miyako;
Tsujino, Kayoko;
Nishio, Makoto;
Kozuka, Takuyo;
Niho, Seiji;
Nihei, Keiji;
Yamamoto, Nobuyuki;
Harada, Hideyuki;
Ishikura, Satoshi;
Tamura, Tomohide

Publication type:

Article

Prognostic significance of CpG island methylator phenotype in surgically resected small cell lung carcinoma.

Published in:

Cancer Science, 2016, v. 107, n. 3, p. 320, doi. 10.1111/cas.12876

By:

Saito, Yuichi;
Nagae, Genta;
Motoi, Noriko;
Miyauchi, Eisaku;
Ninomiya, Hironori;
Uehara, Hirofumi;
Mun, Mingyon;
Okumura, Sakae;
Ohyanagi, Fumiyoshi;
Nishio, Makoto;
Satoh, Yukitoshi;
Aburatani, Hiroyuki;
Ishikawa, Yuichi

Publication type:

Article

Prognostic value of <sup>18</sup>F-fluoroazomycin arabinoside PET/CT in patients with advanced non-small-cell lung cancer.

Published in:

Cancer Science, 2015, v. 106, n. 11, p. 1554, doi. 10.1111/cas.12771

By:

Saga, Tsuneo;
Inubushi, Masayuki;
Koizumi, Mitsuru;
Yoshikawa, Kyosan;
Zhang, Ming‐Rong;
Tanimoto, Katsuyuki;
Horiike, Atsushi;
Yanagitani, Noriko;
Ohyanagi, Fumiyoshi;
Nishio, Makoto

Publication type:

Article

Detection of epidermal growth factor receptor T790M mutation in plasma DNA from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor.

Published in:

Cancer Science, 2013, v. 104, n. 9, p. 1198, doi. 10.1111/cas.12211

By:

Sakai, Kazuko;
Horiike, Atsushi;
Irwin, Darryl L.;
Kudo, Keita;
Fujita, Yoshihiko;
Tanimoto, Azusa;
Sakatani, Toshio;
Saito, Ryota;
Kaburaki, Kyohei;
Yanagitani, Noriko;
Ohyanagi, Fumiyoshi;
Nishio, Makoto;
Nishio, Kazuto

Publication type:

Article

Phase I study of intravenous ASA404 (vadimezan) administered in combination with paclitaxel and carboplatin in Japanese patients with non-small cell lung cancer.

Published in:

Cancer Science, 2011, v. 102, n. 4, p. 845, doi. 10.1111/j.1349-7006.2010.01839.x

By:

Hida, Toyoaki;
Tamiya, Motohiro;
Nishio, Makoto;
Yamamoto, Nobuyuki;
Hirashima, Tomonori;
Horai, Takeshi;
Tanii, Hiromi;
Shi, Michael M.;
Kobayashi, Ken;
Horio, Yoshitsugu

Publication type:

Article

Efficacy of EGFR tyrosine kinase inhibitors in patients having EGFR-activating mutations with or without BIM polymorphisms.

Published in:

2020

By:

Ariyasu, Ryo;
Yanagitani, Noriko;
Tadokoro, Kenichi;
Yamaguchi, Toshikazu;
Uchibori, Ken;
Kitazono, Satoru;
Fujita, Naoya;
Katayama, Ryohei;
Nishio, Makoto

Publication type:

journal article

A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC).

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 37, doi. 10.1007/s00280-014-2478-9

By:

Horinouchi, Hidehito;
Yamamoto, Noboru;
Nokihara, Hiroshi;
Horai, Takeshi;
Nishio, Makoto;
Ohyanagi, Fumiyoshi;
Horiike, Atsushi;
Nakagawa, Kazuhiko;
Terashima, Masaaki;
Okabe, Takafumi;
Kaneda, Hiroyasu;
McKee, Mark;
Carlson, Dawn;
Xiong, Hao;
Tamura, Tomohide

Publication type:

Article

A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC).

Published in:

2014

By:

Horinouchi, Hidehito;
Yamamoto, Noboru;
Nokihara, Hiroshi;
Horai, Takeshi;
Nishio, Makoto;
Ohyanagi, Fumiyoshi;
Horiike, Atsushi;
Nakagawa, Kazuhiko;
Terashima, Masaaki;
Okabe, Takafumi;
Kaneda, Hiroyasu;
McKee, Mark D;
Carlson, Dawn M;
Xiong, Hao;
Tamura, Tomohide

Publication type:

journal article

Phase II trial of gemcitabine and irinotecan in previously treated patients with small-cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 3, p. 503, doi. 10.1007/s00280-007-0496-6

By:

Ohyanagi, Fumiyoshi;
Horiike, Atsushi;
Okano, Yoshio;
Satoh, Yukitoshi;
Okumura, Sakae;
Ishikawa, Yuichi;
Nakagawa, Ken;
Horai, Takeshi;
Nishio, Makoto

Publication type:

Article

Mass Spectrometry to Classify Non-Small-Cell Lung Cancer Patients for Clinical Outcome After Treatment With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Multicohort Cross-Institutional Study.

Published in:

JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 11, p. 838, doi. 10.1093/jnci/djk195

By:

Taguchi, Fumiko;
Solomon, Benjamin;
Gregorc, Vanesa;
Roder, Heinrich;
Gray, Robert;
Kasahara, Kazuo;
Nishio, Makoto;
Brahmer, Julie;
Spreafico, Anna;
Ludovini, Vienna;
Massion, Pierre P.;
Dziadziuszko, Rafal;
Schiller, Joan;
Grigorieva, Julia;
Tsypin, Maxim;
Hunsucker, Stephen W.;
Caprioli, Richard;
Duncan, Mark W.;
Hirsch, Fred R.;
Bunn Jr, Paul A.

Publication type:

Article